Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma Globulin

New England Journal of Medicine

Volumn 318, Issue 20, 1988, Pages 1334-

  Shapiro, Ralph S ^a   Chauvenet, Allen ^b   Mcguire, Warren ^c   Pearson, Andrew ^d   Craft, Alan W ^d   Mcglave, Philip ^a   Filipovich, Alexandra ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c University Medical Center ^*  (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN;

CASE REPORT; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; B-LYMPHOCYTES; CHILD; FEMALE; HUMAN; IMMUNIZATION, PASSIVE; INTERFERON TYPE I; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 0023914384     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198805193182013     Document Type: Letter

References (5)

1. List AF, Greco AF, Vogler LB. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein–Barr virus. J Clin Oncol 1987; 5: 1673–89.
2. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein–Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461–72.
3. Hanto DW, Gajl-Peczalska KJ, Frizzera G, et al. Epstein–Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198: 356–69.
4. Shapiro RS, McClain K, Blazar B, et al. EBV related B cell lymphoproliferative disease after T depleted mismatched bone marrow transplantation. In: Levine PH, Ablashi DV, Nonoyama M, Pearson GR, Glaser R, eds. Epstein–Barr virus and human disease. Clifton, N.J.: Humana Press, 1987: 91–5.
5. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41: 4262–79.